reglab/housing_qa huggingface dataset:
IA Code § 123A.9 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 123A - BEER BREWERS AND WHOLESALERS — CANNED COCKTAILS|Section 123A.9 - Judicial remedies.

123A.9 Judicial remedies.   1. If a brewer or a wholesaler who is a party to an agreement pursuant to this chapter fails to comply with this chapter or otherwise engages in conduct prohibited under this chapter, the aggrieved party may maintain a civil action in district court if the cause of action directly relates to or stems from the relationship of the individual parties under the agreement.   2. A brewer or wholesaler may bring an action for declaratory judgment for determination of any controversy arising under this chapter or out of the brewer and wholesaler agreement.   3. Upon proper petition to the district court, a brewer or wholesaler may obtain injunctive relief against a violation of this chapter.   4. In an action under subsection 1, the district court may grant the relief as the court determines is necessary or appropriate considering the purposes of this chapter. The district court may, if it finds that a brewer has acted in bad faith in invoking the amendment, modification, cancellation, nonrenewal, or termination provision of the agreement between the brewer and wholesaler, or has unreasonably withheld its consent to any assignment, transfer, or sale of the wholesaler’s business, award equitable relief, actual damages, court costs, and attorney’s fees.   5. The prevailing party in an action under subsection 1 shall be entitled to actual damages, court costs, and attorney’s fees at the court’s discretion.   6. With respect to a dispute arising under this chapter or out of the agreement between a brewer and wholesaler, the wholesaler and brewer each has the absolute right, before the wholesaler or brewer has agreed to arbitrate a particular dispute, to refuse to arbitrate that particular dispute. A brewer shall not, as a condition of entering into or renewing an agreement, require the wholesaler to agree to arbitration in lieu of judicial remedies.   7. A brewer shall not take retaliatory action against a wholesaler who files or manifests an intention to file a complaint of alleged violation of state or federal law or regulation by the brewer with the appropriate state or federal regulatory authority. Retaliatory action shall include, but shall not be limited to, refusal without good cause to continue the agreement, or a material reduction in the quality of service or quantity of products available to the wholesaler under the agreement, or impede the normal business operations of the wholesaler.  95 Acts, ch 101, §9  Referred to in §123A.7
IA Code § 123A.10 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 123A - BEER BREWERS AND WHOLESALERS — CANNED COCKTAILS|Section 123A.10 - Waiver — prohibited.

123A.10 Waiver — prohibited.   A brewer shall not require a wholesaler to waive compliance with any provision of this chapter. This chapter shall not be construed to limit or prohibit a good faith settlement of a dispute voluntarily entered into between the parties.  95 Acts, ch 101, §10
IA Code § 123A.11 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 123A - BEER BREWERS AND WHOLESALERS — CANNED COCKTAILS|Section 123A.11 - Indemnification.

123A.11 Indemnification.   A brewer shall fully indemnify and hold harmless the brewer’s wholesaler against any losses, including but not limited to court costs and reasonable attorney fees or damages arising out of complaints, claims, or lawsuits, including but not limited to strict liability, negligence, misrepresentation, or express or implied warranty where the complaint, claim, or lawsuit relates to the manufacture or packaging of beer or other functions by the brewer which are beyond the control of the wholesaler.  95 Acts, ch 101, §11
IA Code § 123A.12 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 123A - BEER BREWERS AND WHOLESALERS — CANNED COCKTAILS|Section 123A.12 - Application to existing agreements.

123A.12 Application to existing agreements.   1. The provisions of this chapter apply to a valid agreement in effect immediately before July 1, 1995, when the first of the following dates occurs:   a. On the effective date of the next amendment, modification, or renewal of the existing valid agreement.   b. On the next anniversary date of the execution of the original agreement between the wholesaler and the brewer.   2. If no written agreement exists, the provisions of the chapter apply to the implied or oral unwritten agreement of a brewer and a wholesaler of that brewery on July 1, 1995.  95 Acts, ch 101, §12
IA Code § 123A.13 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 123A - BEER BREWERS AND WHOLESALERS — CANNED COCKTAILS|Section 123A.13 - Canned cocktails — applicability of chapter.

123A.13 Canned cocktails — applicability of chapter.   The provisions of this chapter that apply to a brewer and wholesaler of beer shall apply to a manufacturer and wholesaler of canned cocktails.  2019 Acts, ch 107, §5, 6
IA Code § 124.101A (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.101A - Administration of controlled substances — delegation.

124.101A Administration of controlled substances — delegation.   Nothing contained in this chapter shall be construed to prevent a physician, dentist, podiatric physician, or veterinarian from delegating the administration of controlled substances under this chapter to a nurse, intern, or other qualified individual or, as to veterinarians, to an orderly or assistant, under the veterinarian’s direction and supervision; all pursuant to rules adopted by the board.  2009 Acts, ch 133, §195
IA Code § 124.101B (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.101B - Factors indicating an imitation controlled substance.

124.101B Factors indicating an imitation controlled substance.   If a substance has not been designated as an imitation controlled substance by the board and if dosage unit appearance alone does not establish that a substance is an imitation controlled substance, the following factors may be considered in determining whether the substance is an imitation controlled substance:   1. The person in control of the substance expressly or impliedly represents that the substance has the effect of a controlled substance.   2. The person in control of the substance expressly or impliedly represents that the substance because of its nature or appearance can be sold or delivered as a controlled substance or as a substitute for a controlled substance.   3. The person in control of the substance either demands or receives money or other property having a value substantially greater than the actual value of the substance as consideration for delivery of the substance.  2017 Acts, ch 145, §3  Referred to in §124.101
IA Code § 124.201A (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.201A - Cannabis-derived products — rules.

124.201A Cannabis-derived products — rules.   1. If a cannabis-derived investigational product approved as a prescription drug medication by the United States food and drug administration is added to the federal schedule of controlled substances by the federal drug enforcement administration and notice of the addition is given to the board, the board shall similarly add the prescription drug medication in the schedule of controlled substances under this chapter.   2. If a cannabis-derived product approved as a prescription drug medication by the United States food and drug administration is eliminated from or revised in the federal schedule of controlled substances by the federal drug enforcement administration and notice of the elimination or revision is given to the board, the board shall similarly eliminate or revise the prescription drug medication in the schedule of controlled substances under this chapter.   3. The board shall adopt rules pursuant to chapter 17A to administer this section. The board may adopt rules on an emergency basis as provided in section 17A.4, subsection 3, and section 17A.5, subsection 2, to administer this section, and the rules shall be effective immediately upon filing unless a later date is specified in the rules. Any emergency rules adopted in accordance with this section shall also be published as a notice of intended action as provided in section 17A.4, subsection 1.   4. Any cannabis-derived investigational product or cannabis-derived product approved as a prescription drug medication by the United States food and drug administration shall not be considered marijuana or cannabimimetic agents, both as defined in section 124.204, tetrahydrocannabinols as used in section 124.204, subsection 4, paragraph “u”, unnumbered paragraph 1, or hemp as defined in section 204.2.  2017 Acts, ch 162, §1, 25; 2020 Acts, ch 1023, §1, 13  Section stricken and rewritten
IA Code § 124.202 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.202 - Controlled substances — listed regardless of name.

124.202 Controlled substances — listed regardless of name.   The controlled substances listed in the schedules in sections 124.204, 124.206, 124.208, 124.210 and 124.212 are included by whatever official name, common or usual name, chemical name, or trade name is designated.  [C73, 75, 77, 79, 81, §204.202]  C93, §124.202
IA Code § 124.203 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.203 - Substances listed in schedule I — criteria.

124.203 Substances listed in schedule I — criteria.   1. The board shall recommend to the general assembly that the general assembly place a substance in schedule I if the substance is not already included therein and the board finds that the substance:   a. Has high potential for abuse; and   b. Has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision.   2. If the board finds that any substance included in schedule I does not meet these criteria, the board shall recommend that the general assembly place the substance in a different schedule or remove the substance from the list of controlled substances, as appropriate.  [C73, 75, 77, 79, 81, §204.203]  C93, §124.203  2009 Acts, ch 41, §34, 263
IA Code § 124.205 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.205 - Substances listed in schedule II — criteria.

124.205 Substances listed in schedule II — criteria.   1. The board shall recommend to the general assembly that the general assembly place a substance in schedule II if the substance is not already included therein and the board finds that:   a. The substance has high potential for abuse;   b. The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and   c. Abuse of the substance may lead to severe psychic or physical dependence.   2. If the board finds that any substance included in schedule II does not meet these criteria, the board shall recommend that the general assembly place the substance in a different schedule or remove the substance from the list of controlled substances, as appropriate.  [C73, 75, 77, 79, 81, §204.205]  C93, §124.205  2009 Acts, ch 41, §35
IA Code § 124.207 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.207 - Substances listed in schedule III — criteria.

124.207 Substances listed in schedule III — criteria.   1. The board shall recommend to the general assembly that the general assembly place a substance in schedule III if the substance is not already included therein and the board finds that:   a. The substance has a potential for abuse which is less than that of the substances listed in schedules I and II;   b. The substance has currently accepted medical use in treatment in the United States; and   c. Abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.   2. If the board finds that any substance included in schedule III does not meet these criteria, the board shall recommend that the general assembly place the substance in a different schedule or remove the substance from the list of controlled substances, as appropriate.  [C73, 75, 77, 79, 81, §204.207]  C93, §124.207  2009 Acts, ch 41, §36
IA Code § 124.209 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.209 - Substances listed in schedule IV — criteria.

124.209 Substances listed in schedule IV — criteria.   1. The board shall recommend to the general assembly that the general assembly place a substance in schedule IV if the substance is not already included therein and the board finds that:   a. The substance has a low potential for abuse when compared with the substances listed in schedule III;   b. The substance has currently accepted medical use in treatment in the United States; and   c. Abuse of the substance may lead to limited physical dependence or psychological dependence when compared with the substances listed in schedule III.   2. If the board finds that any substance included in schedule IV does not meet these criteria, the board shall recommend that the general assembly place the substance in a different schedule or remove the substance from the list of controlled substances, as appropriate.  [C73, 75, 77, 79, 81, §204.209]  C93, §124.209  2009 Acts, ch 41, §37
IA Code § 124.211 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.211 - Schedule V — criteria.

124.211 Schedule V — criteria.   1. The board shall recommend to the general assembly that the general assembly place a substance in schedule V if any substance is not already included therein and the board finds that:   a. The substance has a low potential for abuse when compared with the substances listed in schedule IV;   b. The substance has currently accepted medical use in treatment in the United States; and   c. The substance has limited physical dependence or psychological dependence liability when compared with the controlled substances listed in schedule IV.   2. If the board finds that any substance included in schedule V does not meet these criteria, the board shall recommend that the general assembly place the substance in a different schedule or remove the substance from the list of controlled substances, as appropriate.  [C73, 75, 77, 79, 81, §204.211]  C93, §124.211  2009 Acts, ch 41, §38
IA Code § 124.212A (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.212A - Pharmacy pseudoephedrine sale — restrictions — records — contingent applicability.

124.212A Pharmacy pseudoephedrine sale — restrictions — records — contingent applicability.   A pharmacy, an employee of a pharmacy, or a licensed pharmacist shall do the following:   1. Provide for the sale of a pseudoephedrine product from a locked cabinet or behind the sales counter where the public is unable to reach the product and where the public is not permitted.   2. Require the purchaser to present a government-issued photo identification card identifying the purchaser prior to purchasing a pseudoephedrine product.   3. Provide an electronic logbook for purchasers of pseudoephedrine products to sign.   4. Require the purchaser to sign the electronic logbook. If the electronic logbook is not available, require a signature that is associated with a transaction number.   5. Enter the purchaser’s name, address, date of purchase, time of purchase, name of the pseudoephedrine product purchased, and the quantity sold in the electronic logbook. If the electronic logbook is unavailable, an alternative record shall be kept that complies with the rules adopted by both the office and the board.   6. Determine that the signature in the electronic logbook corresponds with the name on the government-issued photo identification card.   7. Provide notice that a purchaser entering a false statement or misrepresentation in the electronic logbook may subject the purchaser to criminal penalties under 18 U.S.C. §1001.   8. Keep electronic logbook records and any other records obtained from pseudoephedrine purchases if the electronic logbook is unavailable for twenty-four months from the date of the last entry.   9. Disclose electronic logbook information and any other pseudoephedrine purchase records as provided by state and federal law.   10. Comply with training requirements pursuant to federal law.  2009 Acts, ch 25, §3, 9; 2010 Acts, ch 1061, §23  Referred to in §124.212
IA Code § 124.212B (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.212B - Pseudoephedrine sales — tracking — penalty.

124.212B Pseudoephedrine sales — tracking — penalty.   1. The office shall establish a real-time electronic repository to monitor and control the sale of schedule V products containing any detectable amount of pseudoephedrine, its salts, or optical isomers, or salts of optical isomers; ephedrine; or phenylpropanolamine. A pharmacy dispensing such products shall report all such sales electronically to a central repository under the control of the office.   2. The information collected in the central repository is confidential unless otherwise ordered by a court, or released by the lawful custodian of the records pursuant to state or federal law.   3. A pharmacy, an employee of a pharmacy, or a licensed pharmacist shall not be provided access to the stored information in the electronic central repository. However, a pharmacy, an employee of a pharmacy, or a licensed pharmacist shall be provided access to the stored information for the limited purpose of determining what sales have been made by the pharmacy. A pharmacy, an employee of a pharmacy, or a licensed pharmacist shall not be given the obligation or duty to view the stored information.   4. A pharmacy, or an employee of a pharmacy, or a licensed pharmacist shall not be given the obligation or duty to seek information from the central repository if the real-time electronic logbook becomes unavailable for use.   5. If the electronic logbook is unavailable for use, a paper record for each sale shall be maintained including the purchaser’s signature. Any paper record maintained by the pharmacy shall be provided to the office for inclusion in the electronic real-time central repository as soon as practicable.   6. A pharmacy, or an employee of a pharmacy, or a licensed pharmacist shall not be liable, if acting reasonably and in good faith, to any person for any claim which may arise when reporting sales of products enumerated in subsection 1 to the central repository.   7. A person who discloses information stored in the central repository in violation of this section commits a simple misdemeanor.   8. Both the office and the board shall adopt rules to administer this section.   9. The office shall report to the board on an annual basis, beginning January 1, 2010, regarding the repository, including the effectiveness of the repository in discovering unlawful sales of pseudoephedrine products.  2009 Acts, ch 25, §4, 9; 2010 Acts, ch 1069, §13
IA Code § 124.212C (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.212C - Pseudoephedrine advisory council — electronic monitoring.

124.212C Pseudoephedrine advisory council — electronic monitoring. Repealed by 2013 Acts, ch 68, §2.
IA Code § 124.213 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.213 - Pseudoephedrine purchase restrictions from pharmacy or retailer — penalty.

124.213 Pseudoephedrine purchase restrictions from pharmacy or retailer — penalty.   1. A person shall not purchase more than three thousand six hundred milligrams of pseudoephedrine, either separately or collectively, within a twenty-four-hour period from a pharmacy, or more than one package of a product containing pseudoephedrine within a twenty-four-hour period from a retailer in violation of section 126.23A.   2. A person shall not purchase more than seven thousand five hundred milligrams of pseudoephedrine, either separately or collectively, within a thirty-day period from a pharmacy or from a retailer in violation of section 126.23A.   3. A person who violates this section commits a serious misdemeanor.  2005 Acts, ch 15, §2, 14; 2009 Acts, ch 25, §6  Referred to in §124.212
IA Code § 124.301 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.301 - Rules.

124.301 Rules.   The board may, subject to chapter 17A, promulgate rules and charge reasonable fees relating to the registration and control of the manufacture, distribution, and dispensing of controlled substances within this state.  [C73, 75, 77, 79, 81, §204.301]  C93, §124.301  Referred to in §147.82, 155A.43
IA Code § 124.302 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124 - CONTROLLED SUBSTANCES|Section 124.302 - Registration requirements.

124.302 Registration requirements.   1. Every person who manufactures, distributes, dispenses, or conducts research with any controlled substance in this state or who proposes to engage in the manufacture, distribution, or dispensing of or conducting research with any controlled substance within this state, shall obtain and maintain a registration issued by the board in accordance with the board’s rules.   2. Persons registered by the board under this chapter to manufacture, distribute, dispense, or conduct research with controlled substances may possess, manufacture, distribute, dispense, or conduct research with those substances to the extent authorized by their registration and in conformity with the other provisions of this subchapter.   3. The following persons need not register and may lawfully possess controlled substances under this chapter:   a. An agent or employee of any registered manufacturer, distributor, or dispenser of any controlled substance if the agent or employee is acting in the usual course of the agent’s or employee’s business or employment.   b. A common or contract carrier or warehouse operator, or an employee thereof, whose possession of any controlled substance is in the usual course of business or employment.   c. An ultimate user or a person in possession of any controlled substance pursuant to a lawful order of a practitioner or in possession of a schedule V substance.   4. A separate registration is required for each principal place of business or professional practice where the applicant manufactures, distributes, dispenses, or conducts research with controlled substances.   5. The board may inspect the establishment of a registrant or applicant for registration in accordance with the board’s rules.  [C24, 27, 31, 35, §3155; C39, §3169.03, 3169.12; C46, 50, 54, 58, 62, 66, 71, §204.03, 204.12; C73, 75, 77, 79, 81, §204.302]  91 Acts, ch 233, §5  C93, §124.302  2017 Acts, ch 54, §76; 2018 Acts, ch 1138, §24; 2019 Acts, ch 59, §47  Referred to in §124.417, 124.557